In an exciting development that marks a significant milestone in the biocide industry, 4Mediks has achieved authorization of its first biocide product in the categories PT1 (human hygiene), PT2 (disinfectants and algaecides not intended for direct application to humans or animals ), PT3 (veterinary hygiene) and PT4 (surfaces in contact with food and feed) through the European Chemicals Agency (ECHA) by simplified procedure. This achievement not only highlights 4Mediks’ innovation and commitment to excellence, but also highlights the safe and effective nature of its product.
The 4Mediks biocide product is distinguished by its non-toxic composition, which guarantees its safety for both humans and animals. A revolutionary aspect of this product is that it does not require rinsing after use, offering a practical and efficient solution for disinfection in various environments. This attribute underlines the company’s commitment to innovation in the hygiene and disinfection sector, providing safe and accessible solutions for all.
The authorization obtained through ECHA by simplified procedure is a testament to the hard work and dedication of 4Mediks over the last four years. This simplified process is a recognition of the product’s safety and effectiveness, meaning it meets the highest standards set by the agency for the protection of human health and the environment.
4Mediks CEO Juan Antonio Santisteban expressed his excitement at this achievement: “This is a monumental moment for 4Mediks. The authorization of our first biocide product by ECHA validates our commitment to innovation and safety. We are proud to lead the way in developing disinfection solutions that are not only effective but also safe for people and the planet.”
This advancement represents a significant step forward in the field of biocides and establishes 4Mediks as an innovative leader in the market. The company is committed to the continuous development of hygiene and disinfection solutions that address the emerging needs of society, always putting the safety and well-being of its users first.
With the authorization of its biocide product, 4Mediks is preparing to bring its innovations to a global market, promising to revolutionize hygiene and safety practices in multiple sectors. This is just the beginning for 4Mediks as they continue to explore new ways to improve the health and safety of communities around the world.
